Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR2 | P25025 | 20/20 | 1.00 |
| ▸ | CX3CR1 | P49238 | 2/20 | 0.80 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL842319 | 1.00 | CXCR2 (1.00) | CXCR2CX3CR1CXCR1 | |
| SCHEMBL842363 | 0.92 | CXCR2 (1.00) | CXCR2CX3CR1 | |
| SCHEMBL4481036 | 0.92 | CXCR2 (0.84) | CXCR2CX3CR1 | |
| SCHEMBL841694 | 0.91 | CXCR2 (0.84) | CXCR2CX3CR1CXCR1 | |
| SCHEMBL4488684 | 0.90 | CXCR2 (1.00) | CXCR2CX3CR1CXCR1 | |
| SCHEMBL4710712 | 0.90 | CXCR2 (1.00) | CXCR2CX3CR1CXCR1 | |
| SCHEMBL841965 | 0.90 | CXCR2 (0.81) | CXCR2CX3CR1 | |
| SCHEMBL5433102 | 0.89 | CXCR2 (1.00) | CXCR2CX3CR1 | |
| SCHEMBL6859597 | 0.89 | CXCR2 (1.00) | CXCR2CX3CR1CXCR1 | |
| SCHEMBL6865451 | 0.89 | CXCR2 (1.00) | CXCR2CX3CR1CXCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6806273-B1 | 5-THIO-THIAZOLO(4,5-D)PYRIMIDIN-7-YL DERIVATIVES; CHEMOKINE RECEPTOR (ESPECIALLY CXCR2) ACTIVITY MODULATORS | ASTRAZENECA AB (SE) | 2004-10-19 | — | — | US | claimed |
| EP-1104425-B1 | NOVEL THIAZOLOPYRIMIDINE COMPOUNDS | ASTRAZENECA AB (SE) | 2003-01-29 | — | — | EP | claimed |
| US-20150065575-A1 | S100A8/A9 as a Diagnostic Marker and a Therapeutic Target | THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2015-03-05 | — | — | US | disclosed |
| US-20150065575-A1 | S100A8/A9 as a Diagnostic Marker and a Therapeutic Target | THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2015-03-05 | — | — | US | disclosed |
| US-6806273-B1 | 5-THIO-THIAZOLO(4,5-D)PYRIMIDIN-7-YL DERIVATIVES; CHEMOKINE RECEPTOR (ESPECIALLY CXCR2) ACTIVITY MODULATORS | ASTRAZENECA AB (SE) | 2004-10-19 | — | — | US | disclosed |
| EP-1104425-B1 | NOVEL THIAZOLOPYRIMIDINE COMPOUNDS | ASTRAZENECA AB (SE) | 2003-01-29 | — | — | EP | disclosed |